TANAKA et al., 2007 - Google Patents
Two cases of bisphosphonate-associated osteonecrosis of the mandibleTANAKA et al., 2007
View PDF- Document ID
- 3431996388907056132
- Author
- TANAKA N
- KISHIMOTO H
- TAKAOKA K
- HASHITANI S
- SAKURAI K
- URADE M
- Publication year
- Publication venue
- Japanese Journal of Oral and Maxillofacial Surgery
External Links
Snippet
In recent years, bisphosphonates inhibiting bone resorption have been used to treat multiple myeloma, bone metastases from mammary and prostate carcinomas, and osteoporosis and have been proven to be useful. However, mainly in Europe and the USA, osteonecrosis of …
- 229940112871 Bisphosphonate drugs affecting bone structure and mineralization 0 title abstract 7
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P-C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P-C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1339411B1 (en) | Use of zoledronic acid for pain treatment | |
Russell | Bisphosphonates: mode of action and pharmacology | |
Barbosa et al. | Bisphosphonates, old friends of bones and new trends in clinics | |
JP4722375B2 (en) | Administration of biphosphonate | |
JP2009522369A5 (en) | ||
RU2011115356A (en) | COMPOSITION CONTAINING INHIBITING CRYSTALLIZATION OF SUBSTANCE | |
ES2253136T1 (en) | PROCEDURE TO INHIBIT THE OSEA RESORTION. | |
Shima et al. | Inflammatory effects of nitrogen-containing bisphosphonates (N-BPs): modulation by non-N-BPs | |
JP2006500401A5 (en) | ||
TANAKA et al. | Two cases of bisphosphonate-associated osteonecrosis of the mandible | |
F Barghash et al. | Pathophysiology of metastatic bone disease and the role of the second generation of bisphosphonates: from basic science to medicine | |
Shipman, Michael J. Rogers, Karin Vanderkerken, Ben Van Camp, R. Graham G. Russell, Peter I. Croucher | Bisphosphonates-mechanisms of action in multiple myeloma | |
Lazar et al. | Bisphosphonates in bone diseases treatment | |
Berardi et al. | Potential applications of biphosphonates in dental surgical implants | |
Nayak | Application of Bisphosphonates in Dentistry: A Review of Literature. | |
Goodchild et al. | What do you really need to know about bisphosphonates? | |
Bando et al. | Release of Nitrogen-Containing Bisphosphonates (NBPs) from Hydroxyapatite by Non-NBPs and by Pyrophosphate | |
Schmidt et al. | Alendronate inhibition of protein tyrosine phosphatase activity | |
US8623845B1 (en) | Pharmaceutical composition for preventing or treating Diabetes mellitus comprising bisphophonates | |
Park et al. | Mechanism, prevention, risk assessment and treatment in bisphosphonates induced osteonecrosis of the jaw | |
Berenson | Advances in the biology and treatment of myeloma bone disease | |
Jayalakshmi et al. | Bisphosphonates in Oral Diseases: Updates of its implications in Dental Management. | |
Pavkovic et al. | Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates | |
Henk et al. | Clinical findings and main considerations of the use of bisphosphonate in dental implants: a concise systematic review | |
A Lawson et al. | Bisphosphonate therapy in the treatment of multiple myeloma |